Galmed Pharmaceuticals (GLMD) Other Non-Current Assets (2024 - 2025)
Galmed Pharmaceuticals (GLMD) recorded quarterly Other Non-Current Assets of $267000.0 in Q3 2025, little changed quarter-over-quarter from $267000.0 in Q2 2025.
Galmed Pharmaceuticals (GLMD) Other Non-Current Assets (2024 - 2025) Analysis & Trends
Galmed Pharmaceuticals' Other Non-Current Assets history runs 2 years deep, the most recent figure standing at $267000.0 for Q3 2025.
- In Q3 2025, Other Non-Current Assets changed N/A year-over-year to $267000.0; the TTM figure through Sep 2025 stood at $267000.0 (changed N/A YoY), while the FY2024 annual figure was $257000.0, changed N/A from the prior year.
- Other Non-Current Assets was $267000.0 for Q3 2025 at Galmed Pharmaceuticals, roughly flat from $267000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $267000.0 in Q1 2025 to a low of $257000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Galmed Pharmaceuticals | 2.48 Mn | -1.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 267,000.00 |
| Jun 30, 2025 | 267,000.00 |
| Mar 31, 2025 | 267,000.00 |
| Dec 31, 2024 | 257,000.00 |